Angiotensin inhibitors and receptor blockers linked to lower risk of nonmelanoma skin cancer

August 27, 2008

The use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) was associated with a reduced risk of basal cell or squamous cell skin cancers in U.S. veterans, researchers report in the August 26 online issue of the Journal of the National Cancer Institute.

ACE inhibitors and ARBs are frequently prescribed medications for the treatment of high blood pressure. Data from in vitro cell studies and animal models suggest these drugs may slow tumor growth and inhibit angiogenesis. Additionally, some epidemiological studies in humans suggest that ACE inhibitors and ARBs may reduce the risk of nonmelanoma skin cancers.

To test this possibility more specifically, Jennifer Christian, Pharm.D., Ph.D., of the VA Medical Center and Brown University in Providence, R.I., and colleagues performed a cohort study including 1,051 veterans who were at increased risk of keratinocyte skin cancers, including basal cell carcinoma or squamous cell carcinoma. The participants were already enrolled in a VA Cooperative Studies Program trial aimed at testing the efficacy of a topical agent. The researchers collected data on ACE inhibitor and ARBs use from a Veterans Affairs pharmacy database.

With a median follow-up of 3.4 years, the researchers identified 472 cases of basal cell carcinoma, 309 squamous cell cancers, and 200 deaths in the study population. The group taking either an ACE inhibitor or ARBs had a 39 percent relative reduction in incidence of basal cell cancer and a 33 percent relative reduction in squamous cell cancers compared with nonusers. The absolute incidence of the two cancers together was 237 per 1,000 person-years in the ACE inhibitor or ARB users and 374 per 1,000 among nonusers.

The researchers concluded that the use of these agents was associated with a reduction in the risk of nonmelanoma skin cancers but noted that the exact mechanism of action behind the reduction is unknown. "We were surprised to find such a pronounced reduction in [basal cell carcinoma and squamous cell carcinoma] incidence in users of ACE inhibitors or ARBs in such a high-risk group over a short amount of time," the authors write. "Because individuals at normal risk of keratinocyte cancer were not included in our study, the extent to which the results might apply to such individuals is unknown."

Journal of the National Cancer Institute

---

---

	Basal and Squamous Cell Carcinomas: What every primary care physician should know (Postgraduate Medicine) by JTE Multimedia Skin cancer is a major threat to sun-loving Americans, afflicting about 20% of the general population at some point in life. The good news is detection is relatively simple, and screening can easily be incorporated into every physical examination. If basal or squamous cell cancers are found early, treatment is simple and usually successful. However, lifelong surveillance is extremely important in patients who have had skin cancer. Dr Marghoob discusses the characteristics of basal and squamous cell carcinomas and outlines diagnostic and therapeutic options. Original Publication Date: August 1997
	Metastatic cystic squamous cell carcinoma.(PATHOLOGY CLINIC): An article from: Ear, Nose and Throat Journal by Lester D.R. Thompson (Author) This digital document is an article from Ear, Nose and Throat Journal, published by Thomson Gale on May 1, 2005. The length of the article is 527 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Metastatic cystic squamous cell carcinoma.(PATHOLOGY CLINIC) Author: Lester D.R. Thompson Publication: Ear, Nose and Throat Journal (Magazine/Journal) Date: May 1, 2005 Publisher: Thomson Gale Volume: 84 Issue: 5 Page: 272(2) Distributed by Thomson...
	The Skin Cancer Answer: The Natural Treatment for Basal and Sqamous Cell Carcinomasand Keratoses by William I. Lane (Author), Linda Comac (Author) In spite of the steady stream of news about medical breakthroughs, some diseases are on the rise. Nonmelanoma skin cancers (squamous and basal cell carcinomas) occur as often as all other cancers combined. With their previous book on the use of shark cartilage as an anticarcinogen, I. William Lane and Linda Comac challenged the medical establishment. In The Skin Cancer Answer, they now offer a revolutionary approach to skin cancer treatment, describing in a reader-friendly tone the history, use, and effectiveness of a thoroughly tested vegetable component, which is easily applied.
	Squamous Cell Cancer of the Neck (Contemporary Issues in Cancer Imaging) by Robert Hermans (Editor) Part of the bestselling Contemporary Issues in Cancer Imaging series, this book provides crucial imaging information on disease extent in head and neck malignancies. A thorough knowledge of the loco-regional anatomy of this complex area and a proper understanding of the natural disease spread pattern are prerequisites in the interpretation of these imaging studies. After an introductory chapter on epidemiology and clinical signs, this book reviews the pertinent imaging findings for each of the major anatomical subsites. Emphasis is on CT and MRI, but PET and ultrasound are also discussed where appropriate. Reviews on modern surgical and radiotherapeutic techniques are included, helping the reader to understand post-treatment tissue changes and how to differentiate these from tumor...
	Squamous Cell Head and Neck Cancer: Recent Clinical Progress and Prospects for the Future (Current Clinical Oncology) by David J. Adelstein (Editor) Leading expert physicians and investigators from around the world review the state-of-the-art in the management of squamous cell head and neck cancer, with emphasis on coordinating different treatment modalities. The authors address several surgical issues, including laser-based surgery, larynx preservation approaches, salvage surgery, and neck management after non-operative treatment. They also discuss definitive radiation for larynx cancer, brachytherapy, altered fractionation radiation, intensity modulated radiation therapy, and the importance of tumor hypoxia, as well as the role of chemotherapy in sequential, concurrent, and adjuvant multi-modality treatment schedules. Other topics of special interest include targeted and gene therapies, multimodality management of nasopharyngeal...
	Basal and Squamous Cell Skin Cancers of the Head and Neck by Michael J. Miller (Author), Randal S. Weber (Editor), Helmuth Goepfert (Editor) This text provides a multidisciplinary appraoch and detailed discussion of basal and squamous skin cancer surgery, reconstruction and rehabilitation. It covers the aetiologic factors predisposing the development of head and skin cancer, the determination of tumour extent, the surgical resection from skin grafts, and microvascular free tissue transfer. Chapters are included on nursing care for head and neck skin cancer and the social and psychological effects of facial disfigurement.
	Signaling Pathways in Squamous Cancer by Adam B. Glick (Editor), Carter Van Waes (Editor) Squamous epithelia form the lining surface of tissues in contact with the environment: the skin, oral mucosa, esophagus and respiratory tract, the genital tract, and several other specialized tissues. These tissues are at highest risk for exposure to environmental carcinogens such as UV, tobacco smoke and infectious agents. Cancers that form in squamous epithelia are among the most common human solid tumors and have high morbidity and mortality. These cancers include squamous cell carcinoma of the skin, oral cancer, head and neck and esophageal cancer, certain lung cancers and cervical cancer. We propose to organize the book so that the early chapters will focus on individual pathways and more specific mechanisms in both normal function and cancer, while the later chapters will be more...
	Molecular Mechanisms of Basal Cell and Squamous Cell Carcinomas (Medical Intelligence Unit) by Jörg Reichrath (Editor) This book provides a comprehensive, highly readable overview of our current knowledge of the molecular pathology of basal cell and squamous cell carcinomas. The chapters present the newest findings in epidemiology, photocarcinogenesis, genetics, immunology and molecular pathology of these epithelial skin tumours. The book will interest researchers or clinicians interested in the carcinogenesis and biology of basal cell or squamous cell carcinomas.
	SCC antigen in the management of squamous cell carcinoma by Excerpta Medica (Publisher)
	Squamous Cell Carcinoma (Cancer Etiology, Diagnosis and Treatments) by Daniel V. Mortensen (Editor) Squamous cell carcinoma (SCC) is a form of cancer of the carcinoma type that may occur in many different organs, including the skin, lips, mouth, esophagus, urinary bladder, prostate, lungs, vagina and cervix. This new book presents topical research in the study of the ontogeny of squamous cell carcinoma with a focus on the regulation of cell proliferation in oral squamous cell carcinoma. Also discussed is squamous cell carcinoma arising in epidermal cysts and human papillomavirus associated cysts and oral cuniculatum carcinoma.